Patents by Inventor Silke Appel-Dingemanse

Silke Appel-Dingemanse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150087720
    Abstract: S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial 3 to 6 days of treatment the daily dosage is raised so that in total the R-fold (R being the accumulation factor) standard daily dosage is administered and thereafter continued at the standard daily dosage or at a daily dosage lower than the standard daily dosage.
    Type: Application
    Filed: October 16, 2014
    Publication date: March 26, 2015
    Applicant: Novartis AG
    Inventors: John M. Kovarik, Silke Appel-Dingemanse
  • Publication number: 20120071446
    Abstract: S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial 3 to 6 days of treatment the daily dosage is raised so that in total the R-fold (R being the accumulation factor) standard daily dosage is administered and thereafter continued at the standard daily dosage or at a daily dosage lower than the standard daily dosage.
    Type: Application
    Filed: November 22, 2011
    Publication date: March 22, 2012
    Inventors: John M. KOVARIK, Silke Appel-Dingemanse
  • Publication number: 20090275553
    Abstract: S1P receptor modulators or agonists are administered following a dosage regimen whereby during the initial 3 to 6 days of treatment the daily dosage is raised so that in total the R-fold (R being the accumulation factor) standard daily dosage is administered and thereafter continued at the standard daily dosage or at a daily dosage lower than the standard daily dosage.
    Type: Application
    Filed: November 28, 2005
    Publication date: November 5, 2009
    Inventors: John M. Kovarik, Silke Appel-Dingemanse